| 1 | Density | 3.23% | |
| 2 | Hepatitis | 3.23% | |
| 3 | Reduces | 3.23% | |
| 4 | Double | 1.61% | |
| 5 | Consistent | 1.61% | |
| 6 | Surface | 1.61% | |
| 7 | Reveals | 1.61% | |
| 8 | ccRCC | 1.61% | |
| 9 | Risk | 1.61% | |
| 10 | Australia | 1.61% | |
| 11 | BreastScreen | 1.61% | |
| 12 | LDL | 1.61% | |
| 13 | Antigen | 1.61% | |
| 14 | Age | 1.61% | |
| 15 | Exchange | 1.61% | |
| 16 | High | 1.61% | |
| 17 | Therapy | 1.61% | |
| 18 | Cholesterol | 1.61% | |
| 19 | Widespread | 1.61% | |
| 20 | Step | 1.61% | |
| 21 | Regardless | 1.61% | |
| 22 | Screening | 1.61% | |
| 23 | Leader | 1.61% | |
| 24 | Health | 1.61% | |
| 25 | Women | 1.61% | |
| 26 | Breast | 1.61% | |
| 27 | Lowering | 1.61% | |
| 28 | India | 1.61% | |
| 29 | Adjuvant | 1.61% | |
| 30 | Volpara | 1.61% | |
| 31 | Sustained | 1.61% | |
| 32 | Measurement | 1.61% | |
| 33 | DFS | 1.61% | |
| 34 | Plasma | 1.61% | |
| 35 | Data | 1.61% | |
| 36 | Benefit | 1.61% | |
| 37 | Pembrolizumab | 1.61% | |
| 38 | Blood | 1.61% | |
| 39 | Recommended | 1.61% | |
| 40 | Long-Term | 1.61% | |
| 41 | Humans | 1.61% | |
| 42 | Pakistan | 1.61% | |
| 43 | Best | 1.61% | |
| 44 | Rule | 1.61% | |
| 45 | AI-assisted | 1.61% | |
| 46 | Demonstrate | 1.61% | |
| 47 | Reporting | 1.61% | |
| 48 | Type | 1.61% | |
| 49 | Management | 1.61% | |
| 50 | Biological | 1.61% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||